SEC61G and glioblastoma: Lu et al. used quantitative polymerase chain reaction (PCR) to measure gene-level changes in 43 human glioblastoma patients and reported that 77% of patients had increased expression of SEC61G, while the expression of the genes encoding SEC61A1 and SEC61B did not differ from that of healthy individuals (Lu et al., 2009).